Nuclear Medicine: Page 63

NorthStar names Estrem as CFO

By AuntMinnie.com staff writers

NorthStar Medical Technologies has named Paul Estrem to the posts of senior vice president and chief financial officer (CFO).

December 18, 2018

PET/CT facility in India loses isotope license

By AuntMinnie.com staff writers

A lack of expertise and absence of radiation safety has prompted the closure of a PET/CT imaging facility in northwest India, according to a December 18 article in the Kashmir Reader.

December 17, 2018

African nations ponder nuclear energy

By AuntMinnie.com staff writers

Several countries in Africa are considering an investment in nuclear energy, which could have a positive residual effect on the world's supply of medical isotopes.

December 17, 2018

AI could bring ultralow-dose imaging to amyloid PET

By Wayne Forrest

With the help of artificial intelligence (AI), researchers have developed a way to generate diagnostic-quality images from PET/MR scans to detect amyloid deposits with considerably less radiotracer dose. Their findings were published online December 11 in Radiology.

December 17, 2018

Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients

By AuntMinnie.com staff writers

PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) is on par with currently available tools for determining the risk of prostate cancer progression, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 12, 2018

FDA to review Blue Earth's Axumin for brain cancer

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has accepted molecular imaging firm Blue Earth Diagnostics' supplemental new drug application for the use of its Axumin (fluciclovine F-18) PET radiopharmaceutical in brain cancer detection.

December 10, 2018

South Africa purges board of NECSA nuclear agency

By AuntMinnie.com staff writers

The South African government last week dismissed the entire board of South African Nuclear Energy (NECSA), the federal agency that regulates the production of medical radioisotopes in the country.

December 10, 2018

PET tracers help guide breast cancer therapies

By Kate Madden Yee

PET imaging tracers that track breast cancer enzymes could help guide treatment of the disease, especially in women with BRCA mutations and triple-negative subtypes of cancer, according to two studies presented this week at the 2018 San Antonio Breast Cancer Symposium.

December 6, 2018

PET shows efficacy of tuberculosis meningitis drug

By AuntMinnie.com staff writers

With the help of PET scans, researchers at Johns Hopkins Medicine are gathering information on why the drug rifampin is not very effective in treating tuberculosis meningitis of the brain. They reported their results in a study published online December 5 in Science Translational Medicine.

December 6, 2018

Navidea gets patent extension for Lymphoseek

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has received a patent extension for its Lymphoseek radiopharmaceutical.

December 6, 2018

New PET tracer could better connect tau to Alzheimer's

By Wayne Forrest

Clinicians may soon have a new PET tracer to improve the detection of tau protein tangles in the brain, advancing the diagnosis of Alzheimer's disease and subsequently leading to more effective treatments for dementia, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 6, 2018

TOF PET/MRI makes dose reduction viable for breast cancer

By Wayne Forrest

Can clinicians use as little as 10% of the conventional FDG dose and still produce diagnostic-quality images to detect breast cancer? Absolutely. It's feasible using a time-of-flight (TOF) imaging technique with PET/MRI, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 6, 2018

Previous Page

Page 63 of 438

Next Page